Peptide-conjugated Nanoparticle Platforms for Targeted Delivery, Imaging, and Biosensing Applications

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Materials Science

Background:

• Peptides are crucial for developing multifunctional nanostructure platforms.
• Peptide incorporation into nanoparticles (NPs) enables diverse biomedical applications.
• Peptide-modified NPs offer high specificity, low toxicity, and biocompatibility.

Purpose of the Study:

• To review the design and formulation of peptide-based NP platforms.
• To explore the in vitro and in vivo applications of these platforms.
• To provide a future outlook on peptide-conjugated nanomaterials for biomedicine.

Main Methods:

• Literature review of peptide-based nanoparticle design and formulation.
• Analysis of bioconjugation techniques for creating multifunctional NPs.
• Examination of in vitro and in vivo studies utilizing peptide-modified NPs.

Main Results:

• Peptide-modified NPs facilitate targeted drug/gene delivery and imaging.
• Targeting peptides direct NPs to specific tissues via receptor interactions.
• Stimuli-responsive peptide features enable controlled therapeutic release.
• Peptide-based biosensors and imaging agents aid disease detection and monitoring.

Conclusions:

• Peptide-modified NPs represent a significant advancement in nanomedicine.
• These platforms hold great promise for targeted therapies and diagnostics.
• Future research will focus on novel peptide-conjugated nanomaterials for enhanced biomedical applications.